Anti-oxidative effects and harmlessness of asymmetric Au@Fe3O4 Janus particles on human blood cells

Biomaterials

Volumn 35, Issue 25, 2014, Pages 6986-6997

  Landgraf, Lisa ^a   Ernst, Peter ^a   Schick, Isabel ^b   Köhler, Oskar ^b   Oehring, Hartmut ^a   Tremel, Wolfgang ^b   Hilger, Ingrid ^a  

^a JENA UNIVERSITY HOSPITAL   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Amino functionalization; Blood cells; Cell membrane; Cell metabolism; Janus particle; Uptake

Indexed keywords

BIOCOMPATIBILITY; BLOOD; CELL MEMBRANES; CYTOTOXICITY; MANGANESE OXIDE; MEDICAL APPLICATIONS;

AMINO FUNCTIONALIZATION; BLOOD CELLS; CELL METABOLISM; JANUS PARTICLES; UPTAKE;

CYTOLOGY;

ADENOSINE TRIPHOSPHATE; ANTIOXIDANT; DNA; GOLD DERIVATIVE; IRON DERIVATIVE; JANUS NANOPARTICLE; MAGNETIC NANOPARTICLE; METAL OXIDE; UNCLASSIFIED DRUG; FERRIC ION; FERRIC OXIDE; GOLD; METAL NANOPARTICLE; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; ASYMMETRIC SYNTHESIS; BIOCOMPATIBILITY; CELL ADHESION; CELL FATE; CELL METABOLISM; CELL SURFACE; CELL VIABILITY; CHEMICAL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA DAMAGE; DRUG CYTOTOXICITY; GENOTOXICITY; HUMAN; HUMAN CELL; IN VITRO STUDY; INTERNALIZATION; INTRACELLULAR MEMBRANE; MEMBRANE DAMAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURFACE PROPERTY; BLOOD CELL; CELL LINE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; ENDOTHELIUM CELL; METABOLISM; PARTICLE SIZE; PHYSICAL CHEMISTRY; TRANSMISSION ELECTRON MICROSCOPY;

ANTIOXIDANTS; BLOOD CELLS; CELL LINE; CELL SURVIVAL; DNA DAMAGE; ENDOTHELIAL CELLS; FERRIC COMPOUNDS; GOLD; HUMANS; METAL NANOPARTICLES; MICROSCOPY, ELECTRON, TRANSMISSION; PARTICLE SIZE; PHYSICOCHEMICAL PHENOMENA; REACTIVE OXYGEN SPECIES; SURFACE PROPERTIES;

EID: 84902119662     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.04.111     Document Type: Article

References (50)

1. Conde J., Doria G., Baptista P. Noble metal nanoparticles applications in cancer. JDrug Deliv 2012, 2012:751075.
2. Lee D.Y. Highly Effective T2 MR contrast agent based on heparinized superparamagnetic iron oxide nanoparticles. Macromol Res 2011, 19:843-847.
3. Na H.B., Lee J.H., An K., Park Y.I., Park M., Lee I.S., et al. Development of a T1 contrast agent for magnetic resonance imaging using MnO nanoparticles. Angew Chem Int Ed Engl 2007, 46:5397-5401.
4. Thiesen B., Jordan A. Clinical applications of magnetic nanoparticles for hyperthermia. Int J Hyperther 2008, 24:467-474.
5. Yu M.K., Jeong Y.Y., Park J., Park S., Kim J.W., Min J.J., et al. Drug-loaded superparamagnetic iron oxide nanoparticles for combined cancer imaging and therapy invivo. Angew Chem Int Ed Engl 2008, 47:5362-5365.
6. Chien C.C., Chen H.H., Lai S.F., Wu K.C., Cai X.Q., Hwu Y.K., et al. Gold nanoparticles as high-resolution X-ray imaging contrast agents for the analysis of tumor-related micro-vasculature. JNanobiotechnol 2012, 10:1-12.
7. Pustovalov V.K., Babenko V.A. Optical properties of gold nanoparticles at laser radiation wavelengths for laser applications in nanotechnology and medicine. Laser Phys Lett 2004, 1:516-520.
8. Choi J.Y., Lee S.H., Bin Na H., An K., Hyeon T., Seo T.S. Invitro cytotoxicity screening of water-dispersible metal oxide nanoparticles in human cell lines. Bioprocess Biosyst Eng 2010, 33:21-30.
9. Hong S.C., Lee J.H., Lee J., Kim H.Y., Park J.Y., Cho J., et al. Subtle cytotoxicity and genotoxicity differences in superparamagnetic iron oxide nanoparticles coated with various functional groups. Int J Nanomed 2011, 6:3219-3231.
10. Hussain S.M., Javorina A.K., Schrand A.M., Duhart H.M., Ali S.F., Schlager J.J. The interaction of manganese nanoparticles with PC-12 cells induces dopamine depletion. Toxicol Sci 2006, 92:456-463.
11. Shukla R., Bansal V., Chaudhary M., Basu A., Bhonde R.R., Sastry M. Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview. Langmuir 2005, 21:10644-10654.
12. Ying E.B., Hwang H.M. Invitro evaluation of the cytotoxicity of iron oxide nanoparticles with different coatings and different sizes in A3 human T lymphocytes. Sci Total Environ 2010, 408:4475-4481.
13. Xu C., Xie J., Ho D., Wang C., Kohler N., Walsh E.G., et al. Au-Fe3O4 dumbbell nanoparticles as dual-functional probes. Angew Chem Int Ed Engl 2008, 47:173-176.
14. Kirui D.K., Rey D.A., Batt C.A. Gold hybrid nanoparticles for targeted phototherapy and cancer imaging. Nanotechnology 2010, 21:10.
15. Xu C.J., Wang B.D., Sun S.H. Dumbbell-like Au-Fe3O4 Nanoparticles for target-specific platin delivery. JAm Chem Soc 2009, 131:4216-4217.
16. Choi J.S., Jun Y.W., Yeon S.I., Kim H.C., Shin J.S., Cheon J. Biocompatible heterostructured nanoparticles for multimodal biological detection. JAm Chem Soc 2006, 128:15982-15983.
17. Jiang J., Gu H.W., Shao H.L., Devlin E., Papaefthymiou G.C., Ying J.Y. Manipulation bifunctional Fe3O4-Ag heterodimer nanoparticles for two-photon fluorescence imaging and magnetic manipulation. Adv Mater 2008, 20:4403-4407.
18. Sotiriou G.A., Hirt A.M., Lozach P.Y., Teleki A., Krumeich F., Pratsinis S.E. Hybrid, silica-coated, janus-like plasmonic-magnetic nanoparticles. Chem Mater 2011, 23:1985-1992.
19. Hoskins C., Wang L., Cheng W.P., Cuschieri A. Dilemmas in the reliable estimation of the in-vitro cell viability in magnetic nanoparticle engineering: which tests and what protocols?. Nanoscale research letters 2012, 7(77):1-12.
20. Reitsma S., Slaaf D.W., Vink H., van Zandvoort M.A.M.J., Egbrink M.G.A.O. The endothelial glycocalyx: composition, functions, and visualization. Pflug Arch 2007, 454:345-359.
21. Peng S., Lee Y.M., Wang C., Yin H.F., Dai S., Sun S.H. Afacile synthesis of monodisperse Au nanoparticles and their catalysis of CO oxidation. Nano Res 2008, 1:229-234.
22. Schick I., Lorenz S., Gehrig D., Schilmann A.M., Bauer H., Panthofer M., et al. Multifunctional two-photon active silica-coated Au@MnO janus particles for selective dual functionalization and imaging. JAm Chem Soc 2014, 136:2473-2483.
23. Wei Y.H., Bishop K.J.M., Kim J., Soh S., Grzybowski B.A. Making use of bond strength and steric hindrance in nanoscale "synthesis". Angew Chem Int Ed Engl 2009, 48:9477-9480.
24. Park J., An K.J., Hwang Y.S., Park J.G., Noh H.J., Kim J.Y., et al. Ultra-large-scale syntheses of monodisperse nanocrystals. Nat Mater 2004, 3:891-895.
25. Schladt T.D., Graf T., Tremel W. Synthesis and characterization of monodisperse manganese oxide nanoparticles-evaluation of the nucleation and growth mechanism. Chem Mater 2009, 21:3183-3190.
26. 2 core/shell nanoparticles and their application for optical and magnetic resonance imaging. JMater Chem 2012, 22:9253-9262.
27. Cho E.C., Zhang Q., Xia Y.N. The effect of sedimentation and diffusion on cellular uptake of gold nanoparticles. Nat Nanotechnol 2011, 6:385-391.
28. Glei M., Habermann N., Osswald K., Seidel C., Persin C., Jahreis G., et al. Assessment of DNA damage and its modulation by dietary and genetic factors in smokers using the Comet assay: a biomarker model. Biomarkers 2005, 10:203-217.
29. Singh N.P., Mccoy M.T., Tice R.R., Schneider E.L. Asimple technique for quantitation of low-levels of DNA damage in individual cells. Exp Cell Res 1988, 175:184-191.
30. Song M., Moon W.K., Kim Y., Lim D., Song I.C., Yoon B.W. Labeling efficacy of superparamagnetic iron oxide nanoparticles to human neural stem cells: comparison of ferumoxides, monocrystalline iron oxide, cross-linked iron oxide (CLIO)-NH2 and tat-CLIO. Korean J Radiol 2007, 8:365-371.
31. Muller W.A., Gimbrone M.A. Plasmalemmal proteins of cultured vascular endothelial-cells exhibit apical basal polarity - analysis by surface-selective iodination. JCell Biol 1986, 103:2389-2402.
32. Granick S., Jiang S., Chen Q. Janus particles. Phys Today 2009, 62:68-69.
33. Lattuada M., Hatton T.A. Synthesis, properties and applications of janus nanoparticles. Nano Today 2011, 6:286-308.
34. Walther A., Muller A.H.E. Janus particles. Soft Matter 2008, 4:663-668.
35. Pradhan S., Xu L.P., Chen S.W. Janus nanoparticles by interfacial engineering. Adv Funct Mater 2007, 17:2385-2392.
36. Gebauer J.S., Malissek M., Simon S., Knauer S.K., Maskos M., Stauber R.H., et al. Impact of the nanoparticle-protein corona on colloidal stability and protein structure. Langmuir 2012, 28:9673-9679.
37. Lundqvist M., Stigler J., Elia G., Lynch I., Cedervall T., Dawson K.A. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci USA 2008, 105:14265-14270.
38. Bhattacharjee S., Ershov D., Fytianos K., van der Gucht J., Alink G.M., Rietjens I.M.C.M., et al. Cytotoxicity and cellular uptake of tri-block copolymer nanoparticles with different size and surface characteristics. Part Fibre Toxicol 2012, 9(11):1-19.
39. Yin K., Lo I.M.C., Dong H.R., Rao P.H., Mak M.S.H. Lab-scale simulation of the fate and transport of nano zero-valent iron in subsurface environments: aggregation, sedimentation, and contaminant desorption. JHazard Mater 2012, 227:118-125.
40. Tenzer S., Docter D., Rosfa S., Wlodarski A., Kuharev J., Rekik A., et al. Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. ACS Nano 2011, 5:7155-7167.
41. Calabrese E.J., Iavicoli I., Calabrese V. Hormesis: its impact on medicine and health. Hum Exp Toxicol 2013, 32:120-152.
42. Schmeisser S., Schmeisser K., Weimer S., Groth M., Priebe S., Fazius E., et al. Mitochondrial hormesis links low-dose arsenite exposure to lifespan extension. Aging Cell 2013, 12:508-517.
43. Barathmanikanth S., Kalishwaralal K., Sriram M., Pandian S.R., Youn H.S., Eom S., et al. Anti-oxidant effect of gold nanoparticles restrains hyperglycemic conditions in diabetic mice. JNanobiotechnol 2010, 8(16):1-15.
44. Sadkov A.P., Golovanova S.A., Lariontseva N.V., Levchenko L.A. Protective properties of gold in the composition of nanoparticles and Au-rutin complexes. Russ Chem Bull 2011, 60:667-670.
45. Hussain S.M., Hess K.L., Gearhart J.M., Geiss K.T., Schlager J.J. Invitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol InVitro 2005, 19:975-983.
46. Schafer I.A., Kovach M., Price R.L., Fratianne R.B. Human keratinocytes cultured on collagen gels form an epidermis which synthesizes bullous pemphigoid antigens and alpha-2-beta-1 integrins and secretes laminin, type-Iv collagen, and heparan-sulfate proteoglycan at the basal-cell surface. Exp Cell Res 1991, 195:443-457.
47. Chappell D., Jacob M., Hofmann-Kiefer K., Bruegger D., Rehm M., Conzen P., et al. Hydrocortisone preserves the vascular barrier by protecting the endothelial glycocalyx. Anesthesiology 2007, 107:776-784.
48. Jacob M., Bruegger D., Rehm M., Welsch U., Conzen P., Becker B.F. Contrasting effects of colloid and crystalloid resuscitation fluids on cardiac vascular permeability. Anesthesiology 2006, 104:1223-1231.
49. Rehm M., Zahler S., Lotsch M., Welsch U., Conzen P., Jacob M., et al. Endothelial glycocalyx as an additional barrier determining extravasation of 6% hydroxyethyl starch or 5% albumin solutions in the coronary vascular bed. Anesthesiology 2004, 100:1211-1223.
50. Weissenboeck A., Bogner E., Wirth M., Gabor F. Binding and uptake of wheat germ agglutinin-grafted PLGA-nanospheres by Caco-2 monolayers. Pharm Res 2004, 21:1917-1923.